MetaCap

Quoin Pharmaceuticals Insider Trades

NASDAQ: QNRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.50-0.05 (-1.10%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $408.61K
Sales
0 · $0
Shares bought / sold
72.52K / 0
Net activity
Net buying $408,606

Quoin Pharmaceuticals insider activity

Over the last 12 months, Quoin Pharmaceuticals insiders reported 7 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $408,606 and sold $0 worth of stock, for net insider buying of $408,606. The most recent filing shows Carter Denise P. (Chief Operating Officer) buying 20,490 shares at $4.88 on Aug 31, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put QNRX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

QNRX insider transactions

Quoin Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Aug 31, 2026Lawlor Sally BridgetChief Financial OfficerBuy10,244$49.99KForm 4
Aug 31, 2026Culverwell Anthony JamesDirectorBuy6,146$29.99KForm 4
Aug 31, 2026Myers MichaelChief Executive OfficerBuy20,490$99.99KForm 4
Aug 31, 2026Carter Denise P.Chief Operating OfficerBuy20,490$99.99KForm 4
Aug 27, 2026Culverwell Anthony JamesDirectorAward31,352$161.46KForm 4
Aug 27, 2026LANGER DENNISDirectorAward34,534$177.85KForm 4
Oct 14, 2025LANGER DENNISDirectorBuy15,152$128.64KForm 4
Dec 23, 2024Culverwell Anthony JamesDirectorBuy100,000$45.00KForm 4
Dec 23, 2024Myers MichaelChief Executive OfficerBuy555,556$250.00KForm 4
Dec 23, 2024Dunn GordonChief Financial OfficerBuy122,221$55.00KForm 4
Dec 23, 2024Carter Denise P.Chief Operating OfficerBuy555,556$250.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related